DSAC 10-K & 10-Q changes, risk factors and insider trading
Daedalus Special Acquisition Corp. (also DSACU, DSACW) · Nasdaq · Blank Checks · CIK 2082149 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare (only one so far)..
What changed in the latest 10-Q
Risk Factors
Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in the section titled “Risk Factors” contained in our final prospectus for the Initial Public Offering filed with the SEC on December 10, 2025. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.
As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our final prospectus for the Initial Public Offering. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
Largest changes
Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in the section titled “Risk Factors” contained in oursee in full comparisonAnnualfinalReportprospectusonforFormthe10-K,Initial Public Offering filed with the SEC onMarchDecember27,10,2026.2025. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.
As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in oursee in full comparisonAnnualfinalReportprospectusonforFormthe10-K.Initial Public Offering. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
Full comparison: every changed paragraph (2)
Factors that could cause our actual results to
differ materially from those in this Quarterly Report are any of the risks described in the section titled “Risk Factors” contained in our Annualfinal Reportprospectus onfor Formthe 10-K,Initial Public Offering filed with the
SEC on MarchDecember 27,10, 2026.2025. Any of these factors could result in a significant or material adverse effect on our results of operations or financial
condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results
of operations.
As of the date of this Quarterly Report on Form
10-Q, there have been no material changes to the risk factors disclosed in our Annualfinal Reportprospectus onfor Formthe 10-K.Initial Public Offering. We may disclose changes to
such factors or disclose additional factors from time to time in our future filings with the SEC.
Management's Discussion & Analysis (MD&A)
Largest changes
“For the six months ended June 30, 2026, we had net income of $4,161,584, which consists of income earned on investments held in the Trust Account of $4,477,402 and a gain on the expiration of over-allotment liability of $77,000, partially offset by formation, general and administrative expenses of $392,818.”see in full comparison
For the three months endedsee in full comparisonMarchJune31,30, 2026, we had net income of$2,030,262,$2,131,322, which consists of income earned on investments held in the Trust Account of$2,225,943 and gain on expiration of over-allotment liability of $77,000,$2,251,459, partially offset by formation, general and administrative expenses of$272,681.$120,137.
For thesee in full comparisonthreesix months endedMarchJune31,30, 2026, cash used in operating activities was$278,253.$425,645. Net income of$2,030,262$4,161,584 was affected by interest earned on investments held in the Trust Account of$2,225,943$4,477,402 and gain on expiration of over-allotment liability of $77,000. Changes in operating assets and liabilities used$5,572$32,827 of cash for operating activities.
Full comparison: every changed paragraph (13)
We are a blank check company incorporated in the
Cayman Islands on August 7, 2025 formed for the purpose of merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization
or similar business combination with one or more businesses. We intend to effectuate an initial business combination using cash from the
proceeds of ourthe IPOInitial Public Offering and the sale of the private placement units, the proceeds of the sale of our securities in connection with an initial
business combination (pursuant to forward purchase agreements or backstop agreements we may enter), securities issued to the owners of
the target of an initial business combination, debt issued to bank or other lenders or the owners of the target of an initial business
combination, or a combination of the foregoing or other sources.
We have neither engaged in any operations nor
generated any revenues to date. Our only activities from August 7, 2025 (inception) through MarchJune 31,30, 2026 were organizational activities,
those necessary to prepare for the IPO,Initial Public Offering, described below, and identifying a target company for a business combination. We do not expect
to generate any operating revenues until after the completion of our business combination. We generate non-operating income
in the form of interest earned on investments held in the Trust Account. We incur expenses as a result of being a public company for legal,
financial reporting, accounting and auditing compliance.
For the three months ended MarchJune 31,30, 2026, we
had net income of $2,030,262,$2,131,322, which consists of income earned on investments held in the Trust Account of $2,225,943 and gain on expiration
of over-allotment liability of $77,000,$2,251,459, partially offset by formation, general and administrative expenses of $272,681.$120,137.
For the six months ended June 30, 2026, we had net income of $4,161,584, which consists of income earned on investments held in the Trust Account of $4,477,402 and a gain on the expiration of over-allotment liability of $77,000, partially offset by formation, general and administrative expenses of $392,818.
On December 10, 2025, we consummated the
IPO Initial Public Offering of 25,000,000 units at $10.00 per unit, including 2,500,000 units issued pursuant to the partial exercise by the underwriters of their
over-allotment option, generating gross proceeds of $250,000,000. Simultaneously with the closing of the IPO,Initial Public Offering, we consummated the sale
of an aggregate of 685,000 private placement units (the “Private Placement Units”) at a price of $10.00 per Private Placement
Unit, in a private placement to the Sponsor and the representative of the underwriters of the Initial Public Offering, generating gross
proceeds of $6,850,000.
Following the IPO,Initial Public Offering, a total of $250,000,000 was
placed in the trust account (the “Trust Account”). Upon the underwriters’ partial exercise of the over-allotment option,
transaction costs amounted to $14,449,003, consisting of $5,000,000 of cash underwriting fee, $8,750,000 of deferred underwriting fee,
and $699,003 of other offering costs.
For the threesix months ended MarchJune 31,30, 2026, cash used in operating activities
was $278,253.$425,645. Net income of $2,030,262$4,161,584 was affected by interest earned on investments held in the Trust Account of $2,225,943$4,477,402 and gain
on expiration of over-allotment liability of $77,000. Changes in operating assets and liabilities used $5,572$32,827 of cash for operating activities.
As of MarchJune 31,30, 2026, we had investments held
in the Trust Account of $252,761,757.$255,013,216. We intend to use substantially all of the funds held in the Trust Account, including any amounts
representing interest earned on the Trust Account (less income taxes payable, if any), to complete our business combination. To the extent
that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds
held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions
and pursue our growth strategies.
As of MarchJune 31,30, 2026, we had cash of $774,387.
$626,995. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence
on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their
representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate
and complete a business combination.
In order to fund working capital deficiencies
or finance transaction costs in connection with a business combination, the Sponsor, or certain of our officers and directors or their
affiliates may, but are not obligated to, loan us funds as may be required. If we complete a business combination, we would repay such
loaned amounts. In the event that a business combination does not close, we may use a portion of the working capital held outside the
Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of
such Working Capital Loans may be convertible into Private Placement Units of the post business combination entity at a price of $10.00
per unit at the option of the lender. At MarchJune 31,30, 2026, no Working Capital Loans were outstanding.
We have no obligations, assets or liabilities,
which would be considered off-balance sheet arrangements as of MarchJune 31,30, 2026 and December 31, 2025. We do not participate
in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest
entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered
into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments
of other entities, or purchased any non-financial assets.
The underwriters were paid a cash underwriting
discount of $5,000,000 ($0.20 per Unit offered in the IPOInitial Public Offering). Additionally, the underwriters are entitled to a contingent, deferred fee
of $0.35 per Unit, or $8,750,000. The contingent, deferred fee will become payable to the Underwriter from the amounts held in the Trust
Account solely in the event that the Company completes a business combination. Per the underwriting agreement, $0.10 per Unit of such
$0.35 per Unit shall be due solely on amounts remaining in the trust account following all properly submitted shareholder redemptions
in connection with the consummation of our initial business combination and $0.05 per Unit of such $0.35 per Unit shall be allocable by
us to third parties that are members of FINRA, but that are not participating in the IPO,Initial Public Offering, that assist us in consummating our initial business
combination.
The Company accounts for the public and private
warrants issued in connection with itsthe initialInitial publicPublic offeringOffering and the private placement in accordance with the guidance contained in
FASB ASC Topic 815, “Derivatives and Hedging”. Accordingly, the Company evaluated and classified the warrant instruments under
equity treatment at their assigned values. The fair value of public warrants was determined using Black-Scholes Simulation Model. The
public warrants have been classified within shareholders’ deficit and will not require remeasurement after issuance. The key inputs
used in the valuation of the public warrants are as follows:
DSAC insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding DSAC (13F)
None of the 59 investors we track reported a position in their latest 13F.